All stock reportsMAXHEALTH evidence report
Evidence date: 2026-10-01. Research observations only.
What can I do with this stock?
Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.
Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.
Today: intraday
Evidence unavailable
No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
- No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.
Next week: five trading sessions
No qualifying opportunity
No candidate with a primary five-session horizon in the coherent source run.
- No candidate with a primary five-session horizon in the coherent source run.
Long term: one to three years
Research only
A financial screen alone does not establish an investment recommendation.
- A current, source-backed thesis and valuation review is required.
Investment evidence
- Statement coverage
- FULL_STATEMENTS
- Financial source retrieved
- 2026-09-22T14:01:59.601205+00:00
Metrics
- latest_annual_period
- 2026-03-31
- revenue
- 83734500000.0
- net_income
- 14424100000.0
- operating_cash_flow
- 16333200000.0
- free_cash_flow
- 1487900000.0
- total_assets
- 172309400000.0
- total_liabilities
- 64843100000.0
- total_equity
- 107466300000.0
- cash
- 6658000000.0
- total_debt
- 34783600000.0
- revenue_growth
- 0.19136339966365323
- earnings_growth
- 0.34067925790980413
- net_margin
- 0.17225994064573144
- roe
- 0.13421975074976994
- debt_to_equity
- 0.3236698388238918
- cash_conversion
- 1.1323548782939663
- free_cash_flow_margin
- 0.017769258788193635
- trailing_pe
- 73.4091
- forward_pe
- 0.0
- peg_ratio
- Not supplied
- price_to_book
- 10.0654
- dividend_yield
- 0.0018
Other positional research
Research only
1 opportunity assessments; compare evidence and conditions below.
Price Dislocation
Research only. Direction: LONG.
Flags large price dislocations for research without asserting unsupported fundamental quality
- No active, unexpired validation authority for this exact strategy and horizon.
- A source-backed entry, invalidation, exit and cost plan is not supplied.
- Eligible expression
- None selected
- Expression comparison
- No eligible instrument selected.
- Invalidation
- Continued price deterioration or adverse fundamental evidence
- Entry rule
- Not supplied
- Entry range (INR)
- Not supplied
- Exit / review rule
- Not supplied
- Planned exit
- Not supplied
- Plan valid until
- Not supplied
- Promotion reference
- Not supplied
- No reader capital or loss budget supplied
Decision provenance and limitations
- Decision ID
- decision-fc89da3f265b75b80b9b891ee08c13a4866418f7dba400250bdc2fcb6cad695b
- Policy
- stock-decisions-v1
- Evidence bundle hash
- 32ee92c2981223389f275578ede8227feb1dd78a821ddc156adfb02fc357734b
- market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
- validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
- financial-statements: b1a739fe08ac7bdeb52624c7b417e64562da6277400736394e9bcf9a2d7e7625
- daily-price: 6c2f4da53eb442c5517b4d4c568465c2c4dc22c221143fb49ee9d6528a9aad5c
- Conditional research decisions are not orders or personalized position sizes.
- Scenario payoffs are assumptions, not probabilities or expected returns.
- A stop price does not guarantee a maximum loss through a gap or illiquidity.
Download the decision evidence as JSON
Numerical report available. Evidence briefing is queued or awaiting retry.
Cached observations and evidence limits
- Price source verification: REPAIRED.
- The cached closing price on 2026-10-01 was INR 940.95.
- The trailing 5-session price return was -10.04%.
- The trailing 20-session price return was -5.34%.
- The trailing 60-session price return was -13.26%.
- The trailing 250-session price return was -17.15%.
- Average cached traded value over twenty sessions was INR 2,643,087,667.
- The closing price was -22.16% below its highest close in the available trailing year.
- Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-22T14:01:59.601205+00:00 from EODHD.
- The cached financial metric latest annual period is 2026-03-31.
- The cached financial metric revenue growth is 0.19136339966365323.
- The cached financial metric net margin is 0.17225994064573144.
- The cached financial metric roe is 0.13421975074976994.
- The cached financial metric debt to equity is 0.3236698388238918.
- The cached financial metric cash conversion is 1.1323548782939663.
- The cached financial metric free cash flow margin is 0.017769258788193635.
- Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.